Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lotus Pharmaceuticals, Inc. (LTUS) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lotus Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1292087.
Total stock buying since 2010: $0.
Total stock sales since 2010: $4,750.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 0 | $0 | 5,000 | $4,750 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-06 | 0 | $0 | 5,000 | $4,750 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-06-28 | Jin Liu (Director) | Sale | 5,000 | .95 | 4,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of LTUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lotus Pharmaceuticals, Inc. (symbol LTUS, CIK number 1292087) see the Securities and Exchange Commission (SEC) website.